CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

✍ Scribed by Silvio E. Perea; Idania Baladron; Yanelda Garcia; Yasser Perera; Adlin Lopez; Jorge L. Soriano; Noyde Batista; Aley Palau; Ignacio Hernández; Hernán Farina; Idrian Garcia; Lidia Gonzalez; Jeovanis Gil; Arielis Rodriguez; Margarita Solares; Agueda Santana; Marisol Cruz; Matilde Lopez; Carmen Valenzuela; Osvaldo Reyes; Pedro A. López-Saura; Carlos A. González; Alina Diaz; Lila Castellanos; Aniel Sanchez; Lazaro Betancourt; Vladimir Besada; Luis J. González; Hilda Garay; Roberto Gómez; Daniel E. Gómez; Daniel F. Alonso; Phillipe Perrin; Jean-Yves Renualt; Hugo Sigman; Luis Herrera; Boris Acevedo

• Book ID: 106459615
• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 310 KB
• Volume: 356
• Category: Article
• ISSN: 0300-8177
• DOI: 10.1007/s11010-011-0950-y